J&J reports 89% response rate in bladder cancer drug trial
Go back to J&J reports 89% response rate in bladder cancer drug trial| Johnson & Johnson (NYSE: JNJ) | Delayed: 259.33 -3.71 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $263.04 | 52 Week High | $126.07 | |||
| Open | $260.23 | 52 Week Low | $94.28 | |||
| Day High | $261.38 | P/E | 53.91 | |||
| Day Low | $255.93 | EPS | $4.81 | |||
| Volume | 6,802,253 | |||||
